Other Cancers

domain

Cancers not classified in other major groups, including rare cancers and tumors of unspecified or multiple origins.

109

Centers

27,002

Active Trials

55,155

NIH Grants

$26.5B

NCI Funding

General Cancer Types(1000)

NameCenters
Cancers103
Multiple102
Advanced101
Other101
Aggressive98
Carcinoma98
Intervention98
Effect97
Malignancy97
Receptor97
Biomarkers96
Metastatic96
Clinical Trials95
Screening93
Action91
Adenocarcinoma91
Head and Neck Squamous Cell Carcinoma89
Mutation88
Toxicity88
Malignant Solid Neoplasm87
Squamous Cell Carcinoma87
Transcription Factor87
Behavior86
Metastatic Malignant Solid Neoplasm86
Relative86
Disparities85
Pathology85
Advanced Malignant Solid Neoplasm84
Hematopoietic and Lymphoid Cell Neoplasm84
Cancer Prevention83
Cancer Progression82
Domain82
Adult81
Anemia81
Disease Progression81
Head and Neck Carcinoma81
Metastatic Malignant Neoplasm in the Bone80
Surgery80
Germ Cell Tumor79
Malignant Peripheral Nerve Sheath Tumor79
Recurrent Head and Neck Carcinoma79
Hematopoietic and Lymphatic System Neoplasm78
Skin Carcinoma78
Immunology77
Recurrent Skin Carcinoma77
Chordoma76
Etiology76
Severe76
Desmoid Fibromatosis75
Estrogen Receptor Negative75
Hormone Receptor Positive75
Recurrent75
Survivors75
Infections74
Lymphoproliferative Disorder74
Organ74
Endometrioid Adenocarcinoma73
Fibrosis73
Mucinous Adenocarcinoma73
Patient Outcomes73
Basal Cell Carcinoma72
Targeted Therapy72
Cancer Screening71
Syndrome71
High Risk70
Pain70
Susceptibility70
Injury68
Malignant Germ Cell Tumor68
Risk Factor68
Carcinoma In Situ67
Epithelioid Malignant Peripheral Nerve Sheath Tumor67
Malignant Female Reproductive System Neoplasm67
Neoplasm of Uncertain Malignant Potential67
BRIP1 Gene Mutation66
BARD1 Gene Mutation65
BRCA2 Gene Mutation65
Metastatic Disease65
Decision-Making64
Extragonadal Germ Cell Tumor64
Adenoid Cystic Carcinoma63
DNA Repair Disorder63
Transplantation63
Down Syndrome62
Melanocytic Neoplasm62
Partner62
Neurofibromatosis Type 161
Transitional Cell Carcinoma61
Locally Advanced Malignant Solid Neoplasm60
Precancerous Condition60
Survey60
Choriocarcinoma59
Congenital Mesoblastic Nephroma59
Fibrolamellar Carcinoma59
Stromal Neoplasm59
Tomography59
Acinar Cell Carcinoma58
Extramammary Paget Disease58
Ligase58
Metastatic Head and Neck Squamous Cell Carcinoma58
Neuropathy58
Metanephric Tumor57
Psychosocial57
Eyelid Squamous Cell Carcinoma56
Myelofibrosis56
Primary Tumor56
Solid Neoplasm56
Early Stage55
Human Papillomavirus55
Viruses55
Advanced Head and Neck Squamous Cell Carcinoma54
Primary Myelofibrosis54
Carcinomas53
Clear Cell Adenocarcinoma53
Lesion53
Malignant Neoplasm of Unknown Primary53
Rare Disorder53
Relapsed53
Cancer Patient52
Carcinoma of Unknown Primary52
Giant Cell Carcinoma52
Mucinous Cystadenocarcinoma52
Duration51
First-Line51
Pharmacokinetics51
Psychological51
Remission51
Tumor Initiation51
Embryonal Carcinoma50
Papillomavirus50
Cancer Burden49
Microbiota49
Physical Activity49
Basaloid Squamous Cell Carcinoma48
Neoplasia48
Advanced Disease47
Caregivers47
Phosphatase47
Polycythemia Vera47
Search47
Metastatic Malignant Neoplasm in the Soft Tissue46
Nanoparticle46
Symptom46
CDK Gene Mutation45
Neck Squamous Cell Carcinoma of Unknown Primary45
Biospecimen44
Counseling44
Older Adults44
Young Adults44
Blood Samples43
Graft Versus Host Disease43
Inflammatory Bowel Disease43
Lymph Nodes43
Oncologist43
Primary Tumors43
Adult Malignant Hemangiopericytoma42
Autoimmune Disease42
Post Essential Thrombocythemia Myelofibrosis42
Dysplasia41
Doxorubicin40
Gingival Squamous Cell Carcinoma39
Peripheral Primitive Neuroectodermal Tumor39
Advanced Malignant Neoplasm38
Behavioral Intervention38
Heart Failure38
Lymph Node38
Recurrent Disease38
Supportive Care38
Surgeon38
Chemotherapeutic Agent Toxicity37
Complication37
COVID37
Palliative37
Disability35
Health Equity35
Inflammatory Disease35
Mycosis Fungoides35
Metastatic Tumors34
Non-Hodgkin34
Skin Squamous Cell Carcinoma34
Adenoma33
All Cancers33
Cardiovascular Diseases33
Epidermal Growth Factor Receptor33
Metachronous Malignant Neoplasm33
Viral Infection33
Amyloidosis32
Caregiver32
Description32
PD-L1 Positive32
Adjuvant Therapy31
Clinical Response31
KRAS Gene Mutation31
Mucositis31
Circulating Tumor Cells30
Herpesvirus30
HPV Infection30
Infertility30
Motivation30
Obese30
Pancreatitis30
Recurrent Malignant Neoplasm30
Side Effect30
Soft Tissue30
Symptomatic30
Teratoma30
Distance29
Hepatitis B29
Locally Recurrent Head and Neck Squamous Cell Carcinoma29
Antiretroviral Therapy28
Arthritis28
Focus Groups28
Stage III Small Intestinal Adenocarcinoma AJCC v828
Surgical Oncology28
Adenocarcinomas27
Blood Cancers27
Dementia27
Extragonadal Seminoma27
Gender27
Radionecrosis27
Survivor27
Androgen Deprivation Therapy26
NCI-Designated Cancer Center26
Nivolumab26
Chronic Graft Versus Host Disease25
HGSOC25
Immunomodulation25
Multiple Cancers25
Overweight25
Polygenic Risk Score25
Cellular Therapy24
Chemoprevention24
Genomic Alterations24
Mucosa24
Psychological Distress24
Fertility23
Microsatellite Instability23
Neoadjuvant Therapy23
Symptom Management23
Hematopoietic Cell Transplant22
Physical Function22
Sponsor22
Stage IV Sinonasal Cancer AJCC v822
AL Amyloidosis21
Benign Neoplasm21
Cardiomyopathy21
Epilepsy21
HEMATOPOIETIC SYSTEM21
Hypermethylation21
Immune-related Adverse Event21
Locally Advanced Head and Neck Squamous Cell Carcinoma21
Oral Squamous Cell Carcinoma (OSCC)21
SARS-Cov-221
Undefined21
Body Composition20
BRCA1/220
Chromosomal Translocation20
Chronic Pain20
Coping20
Diagnostic Imaging20
Fasting20
Frailty20
Malignant Digestive System Neoplasm20
Nursing20
Self-Management20
Triage20
Any Cancer19
Bone Metastasis19
Bone Neoplasm19
Cancer Education19
Cyclin-Dependent Kinase19
Effusion19
Metastatic Sinonasal Squamous Cell Carcinoma19
Refractory Neoplasm19
Seizures19
Skin Basal Cell Carcinoma19
Stage III Mycosis Fungoides and Sezary Syndrome AJCC v819
Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v819
Cancer Surgery18
Disseminated Tumor Cell18
EGFR Gene Mutation18
Hematopoietic Cell Transplantation18
Hydatidiform Mole18
Influenza18
Radiation Exposure18
Secondary Myelofibrosis18
Sexual Dysfunction and Infertility18
Stage I18
Transplant Recipient18
Alternative Treatment17
Bone Marrow Failure17
Brenner Tumor17
Complete Remission17
Cyclophosphamide17
Cystic17
Deep Vein Thrombosis17
Family Caregivers17
Inflammatory Bowel Disease (IBD)17
Malignant Tumors17
Metabolic Syndrome17
Myasthenia Gravis17
Neurofibromatosis17
NUT Carcinoma17
Papillary Adenocarcinoma17
Polyp17
Sweat Gland Carcinoma17
Abdominal Neoplasm16
Alcohol Use16
Extravasation16
Head and Neck Carcinoma of Unknown Primary16
Head and Neck Squamous Cell Carcinomas16
Hearing Loss16
Incurable Disease16
Malignant Head and Neck Neoplasm16
Primary Cancer16
Smoking History16
Substance Use16
Thrombosis16
Atypical Teratoid Rhabdoid Tumor15
Cardiac Dysfunction15
Conflict15
Healthy Donors15
Immunotherapeutic Agent15
Long-Term Survivors15
Menopause15
Opioid Use15
Relatives15
Somatic Mutation15
Viral Gene15
Bone Loss14
Cancer Control Research14
Clinical Decision Support14
Contrast Agent14
Ductal Carcinoma14
E-cigarette Use14
Front-line14
Gene Fusion14
Graft-versus-Host Disease (GVHD)14
Locally Advanced Malignant Neoplasm14
Lymphoid Malignancies14
Neoplastic Syndrome14
Patient Reported Outcomes14
Sepsis14
Unresectable Malignant Neoplasm14
Adult Cancer Survivors13
Cystectomy13
Digestive System Neoplasm13
Effects of Chemotherapy13
Fibroblast Growth Factor13
Genetic Alteration13
Healthy Volunteers13
History of Cancer13
Metastatic Head and Neck Carcinoma13
Multiple Diseases13
Protein Family13
Recurrent Acute Pancreatitis13
Relapsed or Refractory13
Squamous Cell Neoplasm13
Tobacco Smoking13
Vaping13
Wounds13
Adjuvant Treatment12
Allogeneic Hematopoietic Cell Transplantation12
Cardiovascular Risk12
Drug Toxicity12
EGFR Exon 20 Mutation12
Elevated Expression12
Gynecological Cancer12
Health Behavior12
Hemangiopericytoma12
Hepatitis C Virus12
Inflammatory Disorder12
Internal Medicine12
Oral Leukoplakia12
Oral Mucosa12
Pneumonia12
Smoking Behavior12
Stage III12
Stigma12
Treatment Adherence12
Treatment Plan12
Abnormal DNA Repair11
Aplastic Anemia11
Basement Membrane11
Cytochrome11
Depression, Anxiety11
Diamond-Blackfan Anemia11
Endometriosis11
Gene Mutation11
Health Insurance11
Hematologic Cancers11
Hereditary Cancer11
Malaria11
Malnutrition11
Metastatic Malignant Neoplasm11
Metastatic Transitional Cell Carcinoma11
Patient Education11
Psychiatric Disorder11
Solid Organ Transplant11
Viral Hepatitis11
Acute Pancreatitis10
Anesthesia10
Ataxia Telangiectasia10
EBV-Related Lymphoproliferative Disorder10
Endometrioid Tumor10
Fertility Preservation10
Focus Group10
Food Insecurity10
Genetic Disease10
Geriatric Assessment10
Immune Resistance10
Lymphoproliferative Disease10
Metastatic Triple Negative10
Nephrotoxicity10
Non-cancer Controls10
Organ System10
Patient Engagement10
Radical Cystectomy10
Stable Disease10
Stage II Mycosis Fungoides and Sezary Syndrome AJCC v810
Stage IV Sinonasal Squamous Cell Carcinoma AJCC v710
Active Cancer9
Adolescent and Young Adult Cancer9
Advance Care Planning9
Cancer-related Cognitive Impairment9
Circulating Cell-Free DNA9
Emotions9
Epigenetic Therapy9
Health Care Professional9
Initial Therapy9
Iron Overload9
Margin Assessment9
Neoadjuvant Treatment9
Nicotine Dependence9
Rare Cancer9
Social Needs9
Urothelium9
Adenomatous Polyposis8
Ampulla of Vater Carcinoma8
Brachytherapy8
Cancer Bone8
Chronic Obstructive Pulmonary Disease8
DASATINIB8
Decisional Conflict8
FGFR Gene Amplification8
Financial Toxicity8
Gynecological Cancers8
Human Papillomavirus-Related Carcinoma8
Incontinence8
Intestinal Metaplasia8
Leukoplakia8
Lymph Node Metastasis8
Monoclonal Gammopathy of Undetermined Significance (MGUS)8
Myelofibrosis; Anemia8
Pneumonitis8
Post-Menopausal8
Pulmonary Nodule8
Radiosurgery8
Refractory Malignant Neoplasm8
Sleep Disturbances8
Small Intestinal Carcinoma8
Stage IV8
Tuberous Sclerosis Complex8
Allogeneic Stem Cell Transplant7
Cancer Caregivers7
Cancer-Related Pain7
Cardiovascular Complications7
Complete Surgical Resection7
Connective Tissue7
Coordinator7
Early Relapse7
Familial Cancer7
Geriatrics7
Health Status7
Hematologic Disorders7
Hepatotoxicity7
Herpesvirus Infection7
KRAS Inhibitor7
Lobular Carcinoma7
Locally Advanced Sinonasal Squamous Cell Carcinoma7
Malignant Bone Neoplasm7
Mobile Application7
Neoplastic Disease7
Neurocognitive Impairment7
Post-Transplant Lymphoproliferative Disease7
Refractory Tumor7
Serous Carcinoma7
SMAD47
Stage II Mycosis Fungoides and Sezary Syndrome AJCC v77
TP53 Mutation7
Tuberous Sclerosis7
Advanced Adenocarcinoma6
Bereavement6
Body Image6
Bone Mineral Density6
Cancer Predisposition Syndrome6
Cigarette Smokers6
Clinical Trial Setting6
CMV Infection6
Comorbid Conditions6
Deposit6
Disease Response6
Dyspnea6
Feasibility Studies6
Fever6
Fibrillation6
Fusion Gene6
Genetic Disorder6
Healthy Control6
Hemoglobinopathies6
Hereditary Cancer Syndromes6
Idiopathic Pneumonia Syndrome6
Invasive Malignant Neoplasm6
Joint Pain6
Malignant Male Reproductive System Neoplasm6
Medical Genetics6
Metastatic Bone Disease6
MSI-H6
MYC Amplification6
Oral Premalignant Lesion6
Other Solid Tumor6
Patients With Advanced Solid Tumors6
PLASMACYTOMA6
Portal Hypertension6
Radiation Damage6
Rare Tumors6
RAS Wild Type6
RECTUM6
Recurrent Tumor6
Regulatory Protein6
Relapsed and Refractory6
Schwannoma6
Sibling6
Skin Cancer Prevention6
Surgical Complication6
Tobacco-Related Carcinoma6
Virtual Reality6
Walking6
Acute Pain5
Adenomatous Polyp5
Adenosquamous Carcinoma5
Adolescent and Young Adult (AYA) Cancer Survivors5
Advanced Head and Neck Carcinoma5
Cancer Care Providers5
Carcinoembryonic Antigen5
Cardiovascular Disorder5
Co-morbidity5
Communicable Diseases5
DNA Repair Protein5
EGJ5
Gene Rearrangement5
Grief5
High Tumor Mutation Burden5
Homologous Recombination Deficiency5
HOX Gene5
IDH Mutation5
Immune Deficiencies5
Immunodeficiency Syndrome5
Long-term Effects of Cancer Treatment5
Mammary Cancer5
Menstrual Cycle5
Mood5
MYC Overexpression5
Older Cancer Patients5
Overweight and Obesity5
Patient Preference5
Primary Neoplasm5
Primary Sclerosing Cholangitis (PSC)5
Psychological Factors5
Pulmonary Metastasis5
Respiratory Failure5
SARS-CoV-2 Infection5
Serine Protease5
Smartphone Application5
Smoker5
Soft Tissue Cancer5
Stage III Mycosis Fungoides and Sezary Syndrome AJCC v75
Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v75
Tobacco Dependence5
Vaping Cessation5
Active Cancer Treatment4
Acupuncture4
Adolescents and Young Adults With Cancer4
Advanced Carcinoma4
Anthracycline-induced Cardiotoxicity4
Atrial Fibrillation4
Atypical Hyperplasia4
Benign Prostatic Hyperplasia4
Bloodstream Infection4
Bone Strength4
Calcific Aortic Stenosis4
Cancer Gene Mutation4
Cardiac Disease4
Cardiovascular Events4
Castleman Disease4
Cerebellar Degeneration4
Chemotherapy Effect4
Chemotherapy Induced Peripheral Neuropathy (CIPN)4
Dyskeratosis Congenita4
EBV-associated Malignancies4
Elevated PSA4
Enzyme Inhibitor4
Epithelial Carcinoma4
ErbB Receptors4
Heart Transplant4
Hemangioblastoma4
High Grade Serous Cancer4
Hodgkins Disease4
Human Papillomavirus-Related Malignant Neoplasm4
Hypercalcemia4
Intestinal Diseases4
Late Effect4
Leiomyoma4
Locoregionally Advanced4
Lymphoid Tissue4
Mucinous Neoplasm4
Multiple Chronic Conditions4
Myeloablative Conditioning4
Nevus4
Nonmalignant Neoplasm4
Opioid Consumption4
Oral Chemotherapy4
Osteopetrosis4
Pancreatectomy4
Parents of Children With Cancer4
Pelvic Cancer4
Premalignant Lesion4
Primary Amyloidosis4
Primitive Neuroectodermal Tumor4
Recurrent Skin Squamous Cell Carcinoma4
Respiratory Disease4
Sars-CoV24
Sedentary Behavior4
Self Efficacy4
Sentinel Lymph Node Biopsy4
Solid Organ Tumors4
Solid Tumor Cancers4
Unknown Primary Tumor4
Unknown Primary Tumors4
Acute Respiratory Distress Syndrome3
Adolescent and Young Adult Cancer Patient3
Adolescent Cancer3
Advanced Digestive System Carcinoma3
aGVHD3
Alcohol Drinking3
ALK Gene Mutation3
All Solid Tumors3
Anxiety Disorders3
Any Cancer Diagnosis3
Any Cancer Type3
Artesunate3
Atypical Lobular Hyperplasia3
Benign Neoplasms3
Bone Marrow Fibrosis3
Bone Tumors3
BRAF V600K Mutation Present3
Bronchoalveolar Lavage (BAL)3
Cancer Pathway3
Cancer, Multiple Indications3
Carcinomatosis3
Caregiver Distress3
Cord Blood Transplant3
Cystadenocarcinoma3
Cytogenetic Abnormality3
Dehydration3
Delirium3
Dermatitis3
Distal Esophagus Adenocarcinoma3
Diverticulitis3
EBV Related Carcinoma3
End of Life Care3
Essential Thrombocythemia (ET)3
Estrogen Receptor and/or Progesterone Receptor Positive3
Estrogen Receptor Status3
Fanconi Anemia Complementation Group Gene Mutation3
Fetal Hemoglobin3
FGFR33
First or Second Relapse3
For Donors3
Frail3
Genital Diseases, Male3
Haematological Malignancy3
Head and Neck Cancer Squamous Cell Carcinoma3
Health Knowledge, Attitudes, Practice3
Hematological Diseases3
Hematological Disorder3
Hepatoma3
Hereditary Diseases3
Hereditary Neoplastic Syndrome3
High Grade Squamous Intraepithelial Neoplasia3
Hormone Refractory3
Hot Flushes3
HPV Associated Cancer3
Human Papilloma Virus (HPV) Vaccine3
Immune System Disorder3
Inherited Bone Marrow Failure Syndrome3
Iron Deficiency Anemia3
KMT2A-rearranged3
Lentigo Maligna3
Leukoplakia, Oral3
Line of Therapy3
Lip Cancer3
Locally Advanced Cancer3
Locally Recurrent3
Low Anterior Resection Syndrome3
Malignant Skin Neoplasm3
Malignant Thoracic Neoplasm3
Metastatic Carcinoma3
Multiple Adenomatous Polyps3
Neck Carcinoma3
Neurofibroma3
Newly Diagnosed Cancer Patients3
Non-HPV Locally Advanced Head and Neck Cancer3
Oligometastases3
Oligometastasis3
Optic Neuritis3
Oral Mucositis (Ulcerative)3
Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy3
Oral Mucositis (Ulcerative) Due to Radiation3
Osteonecrosis3
Paroxysmal Nocturnal Hemoglobinuria (PNH)3
Pathologic Processes3
Pelvic Pain3
Peutz-Jeghers Syndrome3
Post-mastectomy3
Posttraumatic Stress Disorder3
PreDiabetes3
Pregnancy Complications3
Prehabilitation3
Protein Kinase Inhibitor3
Psoriasis Vulgaris3
PTEN Gene Deletion3
Pulmonary Metastases3
Question Prompt List3
Recurrent Neoplasm3
Refractory Malignancies3
Resectable Head and Neck Squamous Cell Carcinoma3
Resectable Skin Squamous Cell Carcinoma3
Route of Administration3
Scleroderma3
Sdh3
Secondary AML3
Sedentary Lifestyle3
Serous Tubal Intraepithelial Carcinoma3
Severe Combined Immunodeficiency3
Smoking Reduction3
Spine Metastases3
Stage I Skin Cancer3
Stage II Skin Cancer3
Stage III Ampulla of Vater Cancer3
Stage III Skin Cancer3
Stage IV Ampulla of Vater Cancer3
Stereotactic Radiation3
Taxane-Induced Peripheral Neuropathy3
Therapeutic Procedure3
Tissue Sample3
Transcranial Direct Current Stimulation3
Treatment Side Effects3
Tumor, Benign3
Unresectable or Metastatic Solid Tumors3
Urologic Malignancies3
Viral Reactivation3
3rd Line GIST2
Abdominal Cancer2
Acceptance Processes2
Adenocarcinoma of Esophagus2
Adenocarcinoma of the Ovaries2
Adenocarcinoma of Unknown Primary2
Adenoviral Infection2
Adolescent and Young Adult Cancers2
Adolescent Behavior2
Adult Children2
Adult Epithelioid Hemangioendothelioma2
Adult Malignant Fibrous Histiocytoma of Bone2
Adult Teratoma2
Advanced and/or Metastatic Solid Organ Cancer2
Advanced Care Planning2
Advanced EGFR Positive Solid Tumor2
Advanced Gynecological Cancers2
Advanced Head and Neck Cancer2
Advanced Incurable Cancers2
Advanced Malignancies That Harbor IDHR132 Mutations2
Advanced or Metastatic MTAP-deleted Solid Tumors2
Advanced or Metastatic Solid Malignancies2
Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating Mutations2
Advanced Rare Tumours2
Advanced Solid Malignant Tumors2
Advanced Solid Tumors With HER2 Abnormalities2
Advanced Solid Tumors With HER3 Abnormalities2
Advanced Unresectable or Metastatic Solid Malignancy2
Age2
Aggressive NHL2
ALK Positive Malignancies2
Allogeneic Stem Cell Transplant Recipient2
Androgen Axis Suppression2
Androgen Receptor Positive2
Angiomyolipoma2
Anterior or Posterior Pelvic Exenteration2
Antineoplastic Agents, Immunological2
Appendiceal Cancers2
Atypical Ductal Hyperplasia2
Atypical Squamous Cell of Undetermined Significance2
Autoimmune Nervous System Disorder2
Autologous Transplant Autoimmune2
Autonomic Dysfunction2
Avascular Necrosis2
B-Cell Lymphoproliferative Disorder2
Biallelic Mismatch Repair Deficiency (bMMRD) Positive Patients2
Biochemical Reaction2
Biofeedback2
Biopsy Procedure2
Blastic Plasmacytoid Dendritic Cell Neoplasia2
Blastoma2
Blasts 5 Percent or More of Bone Marrow Nucleated Cells2
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells2
Bone Marrow Cancer2
Bone Marrow Disorder2
Bone Marrow Neoplasms2
Bone Marrow Transplantation Recipient2
Bony Sites2
BRAF NP_004324.2:p.V600E2
Bronchiolitis Obliterans Syndrome2
Bronchoalveolar Lavage Fluid2
Cancer Neck2
Cancer of Esophagus2
Cancer of the Bone2
Cancer of the Esophagus2
Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate2
Cancer-Neoplasms2
Cancer-related Cognitive Dysfunction2
Cardiomyopathies2
Caregiver Burnout2
Caregiver Stress Syndrome2
Castleman's Disease (CD)2
CCUS Clonal Cytopenia of Undetermined Significance2
CD20-Positive Lymphoid Malignancies2
Celiac Disease2
Central Obesity2
Chemotherapy-Associated Paronychia2
Child-Pugh Class A2
Choroid Plexus Tumors2
Chronic Inflammatory Demyelinating Polyneuropathy2
CIDP Transplant2
Cigarette Smoker2
CIPN - Chemotherapy-Induced Peripheral Neuropathy2
cMET-dysregulated Advanced Solid Tumors2
Coronavirus Infection2
Cosmetic Outcome2
Cushing Disease2
DDR Gene Mutation2
Deleterious Mutation2
Depressive Disorder2
Diabetes Mellitus Type 3c2
Diet Habit2
Digestive Organs--Diseases2
Digestive System Carcinoma2
Ductal/Lobular Carcinoma2
Dyspareunia2
EBV Infections2
Embolism2
Endocrine Cancer2
Endometrioid Cancer2
Enhanced Care2
Enterocolitis2
Epithelial Tumors, Malignant2
Epstein-Barr Virus Positive2
ERBB Fusion2
Esophagus Cancer, Adenocarcinoma2
ESR1 Gene Mutation2
Excercise2
Extragonadal Yolk Sac Tumors2
Extramammary Paget's Disease2
Eye and Orbit2
Eye Cancer2
FACT-TOI Scores2
FGFR2 Fusions2
Fibrolamellar Cancer2
Folate Receptor Alpha Positive2
Folliculotropic Mycosis Fungoides2
For Recipients2
Gene Variant2
Generalized Myasthenia Gravis2
Genetic Predisposition to Disease2
Germ Cell Cancer2
Germline Mutation Carrier2
Giant Cell Tumors2
Glomus Tumor, Malignant2
Gonad2
Graft Survival2
GTPase-Activating Protein2
GU Cancer2
Gynecologic Surgery2
Hamartoma2
HCL2
HCT for Neurologic Autoimmune Disorders2
Head and Neck Cancer (H&N)2
Head and Neck Cancer Metastatic2
Head and Neck Cancer Stage III2
Head or Neck Cancer2
Head/Neck SCC2
Heart Diseases2
Hedgehog Inhibitor2
Hematological Non-mast Cell Lineage Disease (AHNMD)2
Hemoglobinopathy in Children2
Hepatitis, Viral, Human2
Hepato Cellular Carcinoma (HCC)2
HER2-activating Mutation2
HER2-normal2
Hernia2
High Folate Receptor-Alpha Expression2
High Risk Hematological Malignancy2
High TMB (Tumor Mutation Burden)2
High-risk Biochemical Recurrence2
HLA-mismatched Bone Marrow Transplantation2
Hodgkin Disease Recurrent2
Hodgkin Disease Refractory2
Hodgkins Disease (HD)2
Hope2
HPV-Negative Squamous Cell Carcinoma2
Hypogammaglobulinemia2
Hypogonadism2
Hypoproliferative Thrombocytopenia2
IDH1 Mutated Solid Tumors2
Immune Effector Cell Associated Neurotoxicity Syndrome2
Improve Sexual Health2
Inherited Cancer Syndrome2
Inherited Metabolic Disorders2
Intractable Cancer Pain2
Irinotecan Sensitive Cancers2
Kahler Disease2
Lambert Eaton Myasthenic Syndrome2
Lip2
Liquid Tumor2
Local Therapy2
Locally Advanced Carcinoma2
Locally Advanced Head and Neck Cancer2
Locally Advanced Head and Neck Carcinoma2
Locally Advanced or Metastatic and Unresectable HCC2
Locally Advanced Unresectable or Metastatic Solid Tumor2
Locally Advanced/Metastatic HER2 Positive Solid Tumors2
Locally Advanced/Metastatic Solid Tumors2
Long Segment Barrett's Esophagus2
Lymph Node Tumors2
Lymphatic Diseases2
Lymphedema Due to Radiation2
Lymphedema of Face2
Lymphedema, Secondary2
Lymphedema; Surgical2
Major Depressive Disorder2
Malignant Extragonadal Germ Cell Tumor2
Malignant Extragonadal Non-Seminomatous Germ Cell Tumor2
Malignant Fibrous2
Malignant Neoplasm of Peritoneum2
Mastectomy Patient2
MDS/MPN Crossover Syndromes2
Medical Device2
Mesothelin Positive2
Mesothelin-expressing Advanced Cancers2
Metabolism Disorder2
Metastatic (Spread to Other Areas of the Body)2
Metastatic Adenocarcinoma2
Metastatic Castration-Resistant Prostatic Cancer2
Metastatic Malignant Neoplasm in the Soft Tissues2
Metastatic Malignant Skin Neoplasm2
Metastatic or Unresectable Solid Tumors2
Metastatic Squamous Neck Cancer With Occult Primary2
Microsatellite Instability-High (MSI-H) Solid Tumors2
Mismatch Repair Deficient (dMMR)2
Mismatch Repair Deficient or MSI-High Solid Tumors2
MLH1 Gene Mutation2
Molecular Mechanisms of Pharmacological Action2
Molecular Sequence Variation2
MRI2
MS Stem Cell Transplant2
MSH2 Gene Mutation2
MSI-H Tumors2
MSS (Microsatellite Stable)2
MTOR2
Mucositis Oral2
Multicentric Angiofollicular Lymphoid Hyperplasia2
Multiple Sclerosis Stem Cell Transplant2
Multiple Sclerosis Transplant2
Myasthenia Gravis Transplant2
Myasthenia Gravis, Generalized2
Myasthenia Gravis, Ocular2
MYC Translocation2
Mycosis Fungoides and Sézary Syndrome2
Negative Control2
Neoplastic Processes2
Nerve Pain2
Neurologic Autoimmune Disease2
Neuropathy, Painful2
Neuropathy;Peripheral2
Newly Diagnosed Disease2
NHL, Relapsed, Adult2
Non Hematologic Cancers2
Non Small Cell2
Non-Atrophic Gastritis2
Non-hematologic Malignancies2
Non-Langerhans-Cell Histiocytosis2

Top Centers for Other Cancers(109)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
2
NCI Comprehensive
3
4
5
NCI Comprehensive
6
NCI Comprehensive
7
NCI Comprehensive
8
NCI Comprehensive
9
NCI Comprehensive
10
NCI Comprehensive
11
12
NCI Comprehensive
13
NCI Comprehensive
14
NCI Comprehensive
15
NCI Comprehensive
16
17
18
19
20
21
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
22
23
NCI Comprehensive
24
25
NCI Comprehensive
26
NCI Clinical
27
NCI Comprehensive
28
NCI Clinical
29
30
NCI Comprehensive
31
NCI Comprehensive
32
33
34
35
36
37
38
GW Cancer CenterWashington, DC
39
40
NCI Basic_laboratory
41
NCI Basic_laboratory
42
NCI Basic_laboratory
43
44
45
46
47
48
49
50
51
52
NCI Comprehensive
53
NCI Comprehensive
54
55
NCI Comprehensive
56
NCI Comprehensive
57
NCI Comprehensive
58
59
NCI Comprehensive
60
NCI Comprehensive
61
62
NCI Comprehensive
63
NCI Comprehensive
64
65
NCI Comprehensive
66
67
68
NCI Comprehensive
69
70
Cedars-Sinai CancerLos Angeles, CA
71
72
NCI Clinical
73
NCI Comprehensive
74
75
76
NCI Comprehensive
77
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
78
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
79
80
81
82
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
83
84
85
86
87
88
89
90
91
92
WVU Cancer InstituteMorgantown, WV
93
94
95
96
97
98
NCI Comprehensive
99
NCI Comprehensive
100
NCI Comprehensive
101
102
NCI Comprehensive
103
104
NCI Comprehensive
105
NCI Basic_laboratory
106
107
BC CancerVancouver, BC
108
109

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →